EyeOnIP Eicarg™ Home User Login User Registration Terms & Conditions Privacy Policy Contact Info About

EyeOnIP

Patents, Trademarks, Trade Secrets, and Copyrights Oh My!

icon

Merck could extend Keytruda patent life with injectable

Key "Keytruda will begin to expire in 2028, opening the door to biosimilars...Merck is testing in clinical trials two versions of the drug that can be injected subcutaneously, a quick alternative to infusions."
Reuters
2022-12-02 06:28:01